GRI Bio, Inc.

GRI · Nasdaq · SIC 2834: Pharmaceutical Preparations
160
SEC Filings

Business Summary

EX-23.1 3 gri-202510k_ex231.htm EX-23.1 Document Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM GRI Bio, Inc. La Jolla, CA We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-274972, 333-276205, 333-280323, 333-286072 and 333-291999) Form S-3 (Nos. 333-279348, 333-283234, 333-274972, 333-272276 and 333-293065), and Form S-8 (Nos. 333-284149, 333-289593, 333-255972 and 333-293063) of GRI Bio, Inc. of our report dated Janu...

Next Earnings

Q2 FY2026 — expected 2026-08-20

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-01-302025-12-310001824293-26-000033EDGAR95K words
2025-03-142024-12-310001824293-25-000050EDGAR
2024-03-282023-12-310001824293-24-000033EDGAR
2023-02-242022-12-310001824293-23-000016EDGAR
2022-02-142021-12-310001824293-22-000004EDGAR
2021-03-292020-12-310001104659-21-042819EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001824293-25-000151EDGAR14K words
2025-08-142025-06-300001824293-25-000106EDGAR
2025-05-152025-03-310001824293-25-000073EDGAR
2024-11-142024-09-300001824293-24-000151EDGAR
2024-08-142024-06-300001824293-24-000105EDGAR
2024-05-102024-03-310001824293-24-000047EDGAR
2023-11-142023-09-300001824293-23-000170EDGAR
2023-08-142023-06-300001824293-23-000147EDGAR
2023-05-152023-03-310001824293-23-000121EDGAR
2022-11-032022-09-300001824293-22-000080EDGAR
2022-07-282022-06-300001824293-22-000072EDGAR
2022-05-092022-03-310001824293-22-000034EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-040001824293-26-000040EDGAR1K words
2026-01-300001824293-26-000030EDGAR
2026-01-280001824293-26-000017EDGAR
2026-01-210001824293-26-000014EDGAR
2026-01-160001824293-26-000011EDGAR
2026-01-150001824293-26-000009EDGAR
2026-01-090001824293-26-000006EDGAR
2026-01-080001824293-26-000002EDGAR
2025-12-120001628280-25-056751EDGAR
2025-12-120001628280-25-056659EDGAR

160 total filings indexed. 132 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001824293
TickerGRI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4d16595e1b1b4e60a1023dd50537ecafc7c6b6fe39d5c042848400e3850c5bdc
parent: 1ebc8c763dc30cb2bc865f3f6487e27d72305fa0630edec8776f1246a8ec6afe
content hash: 6ba0d6d3f479462cef386ce450d50cc65dfe51aa2756ea2fa632fc5877dbb4be
signed: 2026-04-13T04:45:22.333Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf